Skip to main content

Castle Biosciences Inc

Exchange: NASDAQSector: HealthcareIndustry: Diagnostics & Research

CASTELLE

Current Price

$19.13

+1.32%

GoodMoat Value

$28.46

48.8% undervalued
Profile
Valuation (TTM)
Market Cap$568.76M
P/E-44.32
EV
P/B1.21
Shares Out29.73M
P/Sales1.67
Revenue$339.92M
EV/EBITDA

Castle Biosciences Inc (CSTL) Dividends

Dividend Overview

Dividend Yield

Dividend / Share

Key Metrics

Market Cap

$568.76M

P/E Ratio

-44.32

Forward P/E

EPS

$-0.83

PEG Ratio

0.97

Book Value

$15.84

Dividend Yield

Profit Margin

-3.78%

ROE

-2.73%

Dividend History

Dividend Safety

CSTL Dividend Analysis

Castle Biosciences Inc (CSTL) dividend analysis including yield, payout history, and sustainability metrics.

P/E ratio: -44.32. Profit margin: -3.78%. Free cash flow: $28.37M. This page shows Castle Biosciences Inc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Castle Biosciences Inc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.